Citi Cuts United Therapeutics Corp. (UTHR) to Hold

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

August 24, 2011 1:56 PM EDT
Get Alerts UTHR Hot Sheet
Price: $499.73 -0.31%

Rating Summary:
    17 Buy, 11 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
An analyst at Citi downgraded shares of United Therapeutics Corp. (NASDAQ: UTHR) in an intraday research note Wednesday following news its FREEDOM-C(2) trial of treprostinil diethanolamine did not hit its primary endpoint. The stock is down a whopping 18 percent this afternoon.

Citi now rates United Therapeutics shares a Hold, down from Buy previously. The analyst reduced the firm's price target from $74 to $44.

For more ratings news on United Therapeutics Corp. click here and for the rating history of United Therapeutics Corp. click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades

Related Entities

Citi